Novo Nordisk spotlights star diabetes drugs in massive TV ad campaigns

In 2021, pharmaceutical firm Novo Nordisk spent enormous sums of money on advertising diabetes drugs Ozempic and Rybelsus. (Corrected)
Photo: Tidsvilde Stine/Ritzau Scanpix
Photo: Tidsvilde Stine/Ritzau Scanpix
by benjamin werner Christensen, translated by daniel pedersen

(Corrected at 9:25 am, January 25: An earlier version of the article did not contain sales figures in the correct currency for Rybelsus and Ozempic.)

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading